Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Create Stock SIPAutomate your investments in this
Performance
Open
911.90Prev. Close
910.05Volume
12,66,154Total traded value
116 CrUpper Circuit
1,001.05Lower Circuit
819.05Fundamentals
| Market Cap | ₹49,121Cr |
| ROE | 8.01% |
| P/E Ratio(TTM) | 96.50 |
| EPS(TTM) | 9.43 |
| P/B Ratio | 10.98 |
| Dividend Yield | 0.13% |
| Industry P/E | 35.33 |
| Book Value | 82.85 |
| Debt to Equity | 0.62 |
| Face Value | 2 |
Understand Fundamentals
Financials
About Laurus Labs
Laurus Labs is a research-focused, integrated pharmaceutical company that works across four main business areas: CDMO, Generics, APIs, and Biotechnology. The company aims to be a leading player in offering complete solutions for global pharmaceutical needs to help create a healthier world. It has the capacity to formulate over 10 billion tablets and capsules, demonstrating its large-scale manufacturing capabilities.;
| Parent Organisation | Laurus Labs Limited |
| Managing Director | NA |
| NSE Symbol | LAURUSLABS |
Shareholding Pattern
Jun '24
Sep '24
Dec '24
Mar '25
Jun '25
Top Mutual Funds Invested(4)
Similar Stocks
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Sun Pharmaceutical Industries | NA (0.00%) | 37.73 | ||
| Cipla | NA (0.00%) | 22.89 | ||
| Dr Reddy's Laboratories | NA (0.00%) | 19.22 | ||
| Mankind Pharma | NA (0.00%) | 55.88 |